Dietary Supplement Climea Forte 30tabs.

Product Information

Clinical surveillance of all women using estrogen-alone or estrogen plus progestin therapy is important. Adequate diagnostic measures, including directed or random endometrial sampling when indicated, should be undertaken to rule out malignancy in postmenopausal women with undiagnosed persistent or recurring abnormal genital bleeding. A few cases of malignant transformation of residual endometrial implants have been reported in women treated post-hysterectomy with estrogen-alone therapy. For women known to have residual endometriosis post-hysterectomy, the addition of progestin should be considered. Hereditary Angioedema Chlebowski RT, et al. Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women. JAMA. 2003;289:3234-3253. Climea форте ги ублажуваат симптомите на менопауза, ги штитат клетките од слободните радикали, помагаат во одржување на здрави коски, одржување на соодветно ниво на холестерол, помагаат во контрола на телесната тежина и го намалуваат заморот и уморот. Climea forte го прави најтешкиот период во животот на возрасната жена поблаго искуство. Позитивно влијае и на телото на жената и на нејзината психичка состојба. Температурата на телото на жената е изедначена. Се намалува потењето. Вртоглавицата што ја придружува менопаузата исчезнува, особено во нејзиниот прв циклус. Гадење се намалува. Затоа, препаратот се препорачува да го користат жени кои значително ги доживуваат овие заболувања, што им го отежнува нормалното функционирање, работата, комуникацијата со други или вршењето механички активности, како што е возењето. Контраиндикации tablets contain: 250 mg soybean extract, including 100 mg isoflavones, 60 mg hop cone extract, 20 mg flax seeds, 800 mg (100%) calcium *, vitamin D 50 µg (2000 I.U.) (1000%) *, vitamin B6 2.8 mg (200%) *, vitamin E 12 mg alpha-tocopherol equivalent (100%) *, folic acid 400 µg (200%) *.

Subgroup analyses of women 50 to 59 years of age suggest a statistically non-significant reduction in CHD events (CE [0.625 mg]-alone compared to placebo) in women with less than 10 years since menopause (8 versus 16 per 10,000 women-years). 1 In the WHI estrogen plus progestin substudy, a statistically significant 2-fold greater rate of VTE was reported in women receiving daily CE (0.625 mg) plus MPA (2.5 mg) compared to women receiving placebo (35 versus 17 per 10,000 women-years). Statistically significant increases in risk for both DVT (26 versus 13 per 10,000 women-years) and PE (18 versus 8 per 10,000 women-years) were also demonstrated. The increase in VTE risk was demonstrated during the first year and persisted 4. Should a VTE occur or be suspected, estrogen plus progestin therapy should be discontinued immediately. In the WHIMS estrogen-alone ancillary study of WHI, a population of 2,947 hysterectomized women 65 to 79 years of age was randomized to daily CE (0.625 mg)-alone or placebo. Swimming, bathing, or using a sauna while using Climara Forte has not been studied, and these activities may decrease the adhesion of the system and the delivery of estradiol.

Składniki

Climea forte содржи изофлавони од соја збогатени со лен, кој помага за контрола на телесната тежина и екстракт од хмељ, благодарение на кој ги ублажува симптомите на менопауза. Дополнително, додатокот во исхраната Climea forte содржи калциум и витамин Д3, кои помагаат за одржување на здрави коски и витамин Б6, придонесувајќи за намалување на замор и замор во менопаузата. Индикации

Treatment of moderate to severe symptoms ofvulvarand vaginal atrophyassociated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. CLIMEA Forte to preparat którego zadaniem jest złagodzenie objawów menopauzy oraz profilaktycznie w osteoporozie. The WHI estrogen plus progestin substudy reported a statistically non-significant increased risk of ovarian cancer. After an average follow-up of 5.6 years, the relative risk for ovarian cancer for CE plus MPA versus placebo was 1.58 (95 percent CI, 0.77-3.24). The absolute risk for CE plus MPA versus placebo was 4 versus 3 cases per 10,000 women-years. 7 A meta-analysis of 17 prospective and 35 retrospective epidemiology studies found that women who used hormonal therapy for menopausal symptoms had an increased risk for ovarian cancer. The primary analysis, using case-control comparisons, included 12,110 cancer cases from the 17 prospective studies. The relative risks associated with current use of hormonal therapy was 1.41 (95% confidence interval [CI] 1.32 to 1.50); there was no difference in the risk estimates by duration of the exposure (less than 5 years [median of 3 years]vs. greater than 5 years [median of 10 years] of use before the cancer diagnosis). The relative risk associated with combined current and recent use (discontinued use within 5 years before cancer diagnosis) was 1.37 (95% CI 1.27 to 1.48), and the elevated risk was significant for both estrogen-alone and estrogen plus progestin products. The exact duration of hormone therapy use associated with an increased risk of ovarian cancer, however, is unknown. Probable Dementia

Table Of contents

replying to a question/request concerning products, cooperation or business of Aflofarm – the legal basis for processing is your consent or a legitimate interest of the Controller – Article 6(1)(a) and (f) of the GDPR; Should any adhesive remain on the skin after removal of the Climara Forte system, allow the area to dry for 15 minutes. Then gently rubbing the area with an oil-based cream or lotion should remove the adhesive residue. Do not exceed the recommended daily intake. The dietary supplement cannot be used as a substitute (replacement) of a varied diet. A varied diet and a healthy lifestyle are important for health.

In the WHIMS ancillary studies of postmenopausal women 65 to 79 years of age, there was an increased risk of developing probable dementia in women receiving estrogen-alone or estrogen plus progestin when compared to placebo. In the WHI estrogen-alone substudy, the risk of VTE (DVT and PE) was increased for women receiving daily CE (0.625 mg)-alone compared to placebo (30 versus 22 per 10,000 women-years), although only the increased risk of DVT reached statistical significance (23 versus 15 per 10,000 women-years). The increase in VTE risk was demonstrated during the first 2 years 3. Should a VTE occur or be suspected, estrogen-alone therapy should be discontinued immediately. In the event that a system should fall off reapply it to a different location. If the system cannot be reapplied, a new system should be applied for the remainder of the 7-day dosing interval.https://www.poradnikzdrowie.pl/uroda/kosmetyki/kolagen-wlasciwosci-dlaczego-jest-potrzebny-aa-CPEN-tGPd-KgaG.html Climea Forte helps in relieving the symptoms of menopause, including hot flushes, sweating, anxiety, irritability (hops extract). Supports weight control and helps maintain digestive comfort (flax). Supports the maintenance of healthy bones (calcium and vitamin D), contributes to the reduction of tiredness and fatigue (vitamin B6, folates). Also helps to protect cells against oxidative stress (vitamin E) and supports the proper functioning of the nervous system (vitamin B6). handling complaints – legitimate interest of the Controller – Article 6(1)(f) of the GDPR. The basis for personal data processing will be Article 6(1)(b) of the GDPR, where necessary to perform a contract to which you are a party or to take steps at your request prior to entering into a contract. https://www.termedia.pl/Wplyw-zmian-hormonalnych-zachodzacych-w-organizmie-kobiety-na-stan-skory,56,12608,0,0.html